Differential diagnosis in immunohistochemistry with bayes theorem

American Journal of Clinical Pathology

Volumn 131, Issue 5, 2009, Pages 723-730

  Vollmer, Robin T ^a,b  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b DURHAM VA MEDICAL CENTER   (United States)

Author keywords

Bayes theorem; Carcinoma of uncertain origin; Cytokeratin 20; Cytokeratin 7; Differential diagnosis; Immunohistochemistry; Probability

Indexed keywords

CYTOKERATIN 20; CYTOKERATIN 7; TUMOR MARKER;

ARTICLE; BAYES THEOREM; DIFFERENTIAL DIAGNOSIS; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; MATHEMATICAL ANALYSIS; MATHEMATICAL COMPUTING; MATHEMATICAL MODEL; PRIORITY JOURNAL; PROBABILITY; SENSITIVITY ANALYSIS; STATISTICS; TUMOR DIAGNOSIS; CANCER OF UNKNOWN PRIMARY SITE; CHEMISTRY; CLASSIFICATION; NEOPLASM; PREDICTION AND FORECASTING;

BAYES THEOREM; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; KERATIN-20; KERATIN-7; MALE; NEOPLASMS; NEOPLASMS, UNKNOWN PRIMARY; PREDICTIVE VALUE OF TESTS; TUMOR MARKERS, BIOLOGICAL;

EID: 65349151841     PISSN: 00029173     EISSN: None     Source Type: Journal    
DOI: 10.1309/AJCPKF4L6UKBIYSP     Document Type: Article

References (19)

1. Miller I, Miller M. John E. Freund's Mathematical Statistics With Applications. Upper Saddle River, NJ: Pearson Prentice Hall; 2004.
2. Kaufman O, Fietze E, Dietel M. Imrminhistochernische Diagnstik bei Karzinommetastasen mit Unbekanntem Primartumor. Pathologe. 2002;23:183-197.
3. Loy TS, Calauce RD. Utility of cytokeratin immunostaining in separating pulmonary adenocarcinomas from colonic adenocarcinomas. Am J Clin Pathol. 1994;102:764-767.
4. Wauters CCAP, Smedts F, Gerrits LGM, et al. Keratins 7 and 20 as diagnostic markers of carcinomas metastatic to the ovary. Hum Pathol. 1995;26:852-855.
5. Maeda T, Kajiyama K, Adachi E, et al. The expression of cytokeratins 7, 19, and 20 in primary and metastatic carcinomas of the liver. Mod Pathol. 1996;9:901-909.
6. Loy TS, Calauce RD, Keeney GL. Cytokeratin immuno- staining in differentiating primary ovarian carcinoma from metastatic colonic adenocarcinoma. Mod Pathol. 1996;9:1040-1044.
7. Berezowski K, Stastny JF, Kornstein MJ. Cytokeratins 7 and 20 and carcinoembryonic antigen in ovarian and colonic carcinoma. Mod Pathol. 1996;9:426-429.
8. Perry A, Parisi JE, Kurtin PJ. Metastatic adenocarcinoma to the brain: an immunohistochemical approach. Hum Pathol. 1997;28:938-943.
9. Harlamert HA, Mira J, Bejarano PA, et al. Thyroid transcription factor-1 and cytokeratins 7 and 20 in pulmonary and breast carcinoma. Acta Cytol. 1998;42:1382-1388.
10. Lagendijk JH, Mullink H, Van Diest PJ, et al. Tracing the origin of adenocarcinomas with unknown primary using immunohistochemistry: differential diagnosis between colonic and ovarian carcinomas as primary sites. Hum Pathol. 1998;29:491-497.
11. Tot T. Adenocarcinomas metastatic to the liver: the value of cytokeratins 20 and 7 in the search for unknown primary tumors. Cancer. 1999;85:171-177.
12. Bassily NH, Vallorosi CJ, Akdas G, et al. Coordinate expression of cytokeratins 7 and 20 in prostate adenocarcinoma and bladder urothelial carcinoma. Am J Clin Pathol. 2000;113:383-388.
13. Chu P, Wu E, Weiss LM. Cytokeratin 7 and cytokeratin 20 expression in epithelial neoplasms: a survey of 435 cases. Mod Pathol. 2000;13:962-972.
14. Cathro HP, Stoler MH. Expression of cytokeratins 7 and 20 in ovarian neoplasia. Am J Clin Pathol. 2002;117:944-951.
15. Chu PG, Weiss LM. Immunohistochemical characterization of signet-ring cell carcinomas of the stomach, breast, and colon. Am J Clin Pathol. 2004;121:884-892.
16. Goldstein NS, Bassi D. Cytokeratins 7, 17, and 20 reactivity in pancreatic and ampulla of Vater adenocarcinomas: percentage of positivity and distribution is affected by the cut-point threshold. Am J Clin Pathol. 2001;115:695-702.
17. Pavlidis N, Briasoulis E, Hainsworth J, et al. Diagnostic and therapeutic management of cancer of an unknown primary. Eur J Cancer. 2003;39:1990-2005.
18. Shaw PHS, Adams R, Jordan C, et al. A clinical review of the investigation and management of carcinoma of unknown primary in a single cancer network. Clin Oncol (R Coll Radiol). 2007;19:87-95.
19. Jemal A, Siegel R, Ward E, et al. Cancer statistics, 2008. CA Cancer J Clin. 2008;58:71-96.